ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 30 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,409,000 | +25.1% | 1,020,748 | 0.0% | 0.03% | +78.9% |
| Q2 2021 | $2,725,000 | +24.8% | 1,020,748 | 0.0% | 0.02% | -24.0% |
| Q1 2021 | $2,184,000 | -13.4% | 1,020,748 | 0.0% | 0.02% | -10.7% |
| Q4 2020 | $2,521,000 | +21.1% | 1,020,748 | 0.0% | 0.03% | -24.3% |
| Q3 2020 | $2,082,000 | -31.1% | 1,020,748 | 0.0% | 0.04% | -30.2% |
| Q2 2020 | $3,021,000 | +12.0% | 1,020,748 | 0.0% | 0.05% | -14.5% |
| Q1 2020 | $2,698,000 | -46.8% | 1,020,748 | 0.0% | 0.06% | -17.3% |
| Q4 2019 | $5,073,000 | -58.3% | 1,020,748 | -50.0% | 0.08% | -16.7% |
| Q3 2019 | $12,168,000 | +84.8% | 2,041,496 | +100.0% | 0.09% | -9.1% |
| Q2 2019 | $6,584,000 | -4.6% | 1,020,748 | 0.0% | 0.10% | -27.2% |
| Q1 2019 | $6,900,000 | +66.1% | 1,020,748 | 0.0% | 0.14% | +103.0% |
| Q4 2018 | $4,154,000 | -62.6% | 1,020,748 | 0.0% | 0.07% | -52.5% |
| Q3 2018 | $11,106,000 | – | 1,020,748 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GARDNER LEWIS ASSET MANAGEMENT L P | 1,249,778 | $2,750,000 | 0.55% |
| Beryl Capital Management LLC | 1,131,772 | $2,490,000 | 0.26% |
| DELTEC ASSET MANAGEMENT LLC | 155,614 | $342,000 | 0.08% |
| Knott David M Jr | 41,700 | $92,000 | 0.04% |
| TPG GP A, LLC | 1,020,748 | $2,246,000 | 0.04% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 40,900 | $90,000 | 0.01% |
| Ergoteles LLC | 135,323 | $298,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,600 | $292,000 | 0.01% |
| Virtu Financial LLC | 20,027 | $44,000 | 0.00% |
| GABELLI FUNDS LLC | 59,100 | $130,000 | 0.00% |